According to TheBlock, Binance Labs announced an undisclosed investment in the DeSci project BIOProtocol. This investment is Binance Labs' first investment in the DeSci field, and BIOProtocol aims to use blockchain technology to change the financing and commercialization of early scientific research. Its platform enables scientists, patients, and investors worldwide to fund, develop, and collectively own new drugs through biotechnology DAO, addressing gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity, and emerging health challenges. @uih